Methylnaltrexone bromide
USP/1430735 - United States Pharmacopeia (USP) Reference Standard
Synonym: 17-
CAS Number: 73232-52-7
Empirical Formula (Hill Notation): C21H26NO4 · Br
Molecular Weight: 436.34
MDL Number: MFCD06407831
Linear Formula: C21H26NO4 · Br
Product Type: Chemical
| API family | methylnaltrexone |
| application(s) | pharmaceutical |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C21H25NO4.BrH/c1-22(11 |
| InChI key | IFGIYSGOEZJNBE-KNLJMPJLSA |
| manufacturer/tradename | USP |
| SMILES string | [Br-].C[N@+]1(CC[C@]23[C@ |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Methylnaltrexone bromide USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. |
| Biochem/physiol Actions: | Methylnaltrexone bromide is a narcotic antagonist. |
| Biochem/physiol Actions: | Methylnaltrexone bromide is a narcotic antagonist. It is a peripheral mu-opiod receptor antagonist that cannot cross the blood-brain barrier. It reverses many opioid side-effects without interfering with pain relief. |
| General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia ![]() |
| Other Notes: | Sales restrictions may apply. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |

